The Clinical Trials Summit of Pakistan 2025 marked a significant milestone for the country's healthcare landscape. Hosted by the Clinical Trials Unit (CTU) at Aga Khan University (AKU), in collaboration with National University of Medical Sciences (NUMS), this two-day event brought together leading professionals, researchers, and healthcare providers to discuss the latest trends, challenges, and advancements in clinical trials.

Dr. Saeed Hamid, Director of the Clinical Trials Unit at AKU, reflected on the impact of global clinical trials, stating: “One satisfying aspect of participating in global clinical trials is the opportunity for our patients to experience cutting-edge therapies for diseases, such as  hepatitis Delta, which currently have no approved treatment available."

The summit featured a series of keynote speeches and panel discussions addressing a wide range of topics, including emerging trends, regulatory frameworks, innovation, community engagement, ethical considerations, rare diseases and patient-centric approaches to clinical trial design. Dr. Bin Chen, CEO of HuaHui Health, commented on the summit's success in fostering collaboration, stating that “The conference was an exceptional platform for collaboration, innovation, and knowledge-sharing."